Lord, Abbett & Co’s Acceleron Pharma Inc. XLRN Stock Holding History

Lord, Abbett & Co’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-560,040	Closed	-$96.4M	–	712
2021 Q3	$96.4M	Buy	560,040 +108,953	+24%	+$18.8M	0.23%	138
2021 Q2	$56.6M	Sell	451,087 -16,558	-4%	-$2.08M	0.14%	226
2021 Q1	$63.4M	Sell	467,645 -451,320	-49%	-$61.2M	0.16%	200
2020 Q4	$118M	Sell	918,965 -115,019	-11%	-$14.7M	0.31%	95
2020 Q3	$116M	Buy	1,033,984 +756,387	+272%	+$85.1M	0.37%	73
2020 Q2	$26.4M	Buy	277,597 +20,980	+8%	+$2M	0.09%	331
2020 Q1	$23.1M	Buy	+256,617	New	+$23.1M	0.1%	298
2018 Q4	–	Sell	-124,385	Closed	-$7.12M	–	850
2018 Q3	$7.12M	Buy	124,385 +10,051	+9%	+$575K	0.02%	684
2018 Q2	$5.55M	Sell	114,334 -2,180	-2%	-$106K	0.02%	726
2018 Q1	$4.56M	Buy	116,514 +35,382	+44%	+$1.38M	0.01%	743
2017 Q4	$3.44M	Sell	81,132 -1,972	-2%	-$83.7K	0.01%	806
2017 Q3	$3.1M	Sell	83,104 -4,839	-6%	-$181K	0.01%	820
2017 Q2	$2.67M	Sell	87,943 -1,488	-2%	-$45.2K	0.01%	841
2017 Q1	$2.37M	Sell	89,431 -1,000	-1%	-$26.5K	0.01%	828
2016 Q4	$2.31M	Sell	90,431 -72,614	-45%	-$1.85M	0.01%	820
2016 Q3	$5.9M	Buy	163,045 +18,112	+12%	+$656K	0.02%	700
2016 Q2	$4.93M	Buy	144,933 +19,469	+16%	+$662K	0.02%	713
2016 Q1	$3.31M	Sell	125,464 -25,776	-17%	-$680K	0.01%	778
2015 Q4	$7.37M	Buy	151,240 +72,815	+93%	+$3.55M	0.02%	658
2015 Q3	$1.95M	Sell	78,425 -85,272	-52%	-$2.12M	0.01%	849
2015 Q2	$5.18M	Sell	163,697 -216,972	-57%	-$6.87M	0.01%	762
2015 Q1	$14.5M	Buy	380,669 +134,767	+55%	+$5.13M	0.04%	545
2014 Q4	$9.58M	Buy	245,902 +160,235	+187%	+$6.24M	0.02%	625
2014 Q3	$2.59M	Sell	85,667 -35,016	-29%	-$1.06M	0.01%	850
2014 Q2	$4.1M	Buy	120,683 +10,318	+9%	+$351K	0.01%	831
2014 Q1	$3.81M	Buy	110,365 +11,165	+11%	+$385K	0.01%	834
2013 Q4	$3.93M	Buy	+99,200	New	+$3.93M	0.01%	899